| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 11 | |
| #2 | Australia | 5 | |
| #3 | Brazil | 3 | |
| #4 | Canada | 3 | |
| #5 | Republic of Korea | 3 | |
| #6 | Mexico | 3 | |
| #7 | United States | 3 | |
| #8 | Chile | 2 | |
| #9 | Costa Rica | 2 | |
| #10 | Israel | 2 | |
| #11 | Morocco | 2 | |
| #12 | Singapore | 2 | |
| #13 | South Africa | 2 | |
| #14 | Colombia | 1 | |
| #15 | Philippines | 1 | |
| #16 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Computer technology | |
| #4 | Measurement | |
| #5 | Biotechnology |
| # | Name | Total Patents |
|---|---|---|
| #1 | Campbell David | 39 |
| #2 | Duron Sergio G | 32 |
| #3 | Mckew John C | 10 |
| #4 | Shen Min | 10 |
| #5 | Vollrath Benedikt | 10 |
| #6 | Huang Wenwei | 10 |
| #7 | Behnke Mark | 10 |
| #8 | Wade Warren | 7 |
| #9 | Durón Sergio G | 5 |
| #10 | Lichter Jay | 3 |
| Publication | Filing date | Title |
|---|---|---|
| US2014323478A1 | Serine/threonine kinase inhibitors | |
| AU2012330498A1 | PAK inhibitors for the treatment of cancer | |
| EP2773643A1 | Pak inhibitors for the treatment of fragile x syndrome | |
| AU2012313399A1 | 8-ethyl-6-(aryl)pyrido [2,3-d]pyrimidin-7(8H) -ones for the treatment of nervous system disorders and cancer | |
| EP2580214A2 | 6-(sulfonylaryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |